Post-acne atrophic scars.
Conditions
Interventions
Treatment side:Heling Cream
Control side:base cream
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 44 Years
Inclusion criteria
Inclusion criteria: 1) Male or female subjects aged 18 to 44 with acne atrophic scars requiring full-face non-ablative non-ablative fractional laser treatment; 2) Fitzpatrick skin types II-IV; 3) Agree to participate in this study and follow the scheduled follow-ups, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Individuals who are pregnant, breastfeeding, or planning to become pregnant during the follow-up period; 2) Those with a history of keloids or hypertrophic scarring; 3) Participants who are currently involved in other clinical studies; 4) Individuals with other skin conditions on the face that may affect the evaluation of treatment efficacy; 5) Those who have received photoelectric therapy or topical products promoting epidermal regeneration on the face within the last month; 6) Patients with severe systemic skin diseases, internal diseases, coagulation disorders, psychological or psychiatric conditions, or infectious diseases; 7) Individuals with known allergies to any components of topical products or to lidocaine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Melanin score; | — |
Countries
China
Contacts
Public ContactXiuli Wang
Shanghai Skin Disease Hospital
Outcome results
None listed